Literature DB >> 6974407

Long-term immunological investigation of malignant intracranial gliomas.

M Gerosa, G Semenzato, G Amadori, A Olivi, A Rotilio, M Zuccarello, G Iraci.   

Abstract

In this study, 118 consecutive adult patients with supratentorial gliomas underwent preoperative immunological monitoring, with particular regard to B-lymphocyte and T-lymphocyte markers. Most patients were treated surgically and with radiotherapy. Three months later, they were readmitted for postoperative immunological investigation and follow-up control. A total of 76 cases could thus be completely investigated and were statistically eligible for evaluation. A pronounced failure of T-cell-mediated immunity was observed: "E-active" rosette-forming cells and mitogen-induced blastogenesis tests turned out to be markedly depressed, with a slight postoperative recovery. Spontaneous cell-mediated cytotoxicity was significantly (p less than 0.01) increased both in preoperative and postoperative findings. The main immunodiagnostic patterns (immunoglobulins assay, surface immunoglobulins, "mouse" rosettes) concerning the B-cell-dependent "pool" were found to be within normal limits.

Entities:  

Mesh:

Year:  1981        PMID: 6974407     DOI: 10.1016/s0090-3019(81)80065-1

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Lymphocyte subsets in patients with brain tumors.

Authors:  M Uegaki; S Kobayashi; S Kuramoto; M M Yokoyama
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

2.  Cellular immunity and complement levels in hosts with brain tumours.

Authors:  M Matsutani; T Suzuki; T Hori; H Terao; K Takakura; K Nishioka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

3.  Immunologic status in children with brain tumors and the effect of therapy.

Authors:  R Kebudi; I Ayan; E Darendeliler; L Ağaoğlu; S Ekmekçioğlu; T Yağci; S Pişkin; N Bilge
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma.

Authors:  Derek A Wainwright; Sadhak Sengupta; Yu Han; Ilya V Ulasov; Maciej S Lesniak
Journal:  PLoS One       Date:  2010-10-23       Impact factor: 3.240

5.  Immunological studies in patients with central nervous system tumors.

Authors:  L Palma; V Moschese; E Galli; C Barbieri; V R Lombardi; P Rossi
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.